SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Hayden Tanya – ‘4’ for 6/19/22 re: Acer Therapeutics Inc.

On:  Wednesday, 6/22/22, at 4:06pm ET   ·   For:  6/19/22   ·   Accession #:  1209191-22-38667   ·   File #:  1-33004

Previous ‘4’:  None   ·   Next & Latest:  ‘4’ on 3/16/23 for 3/14/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/22/22  Hayden Tanya                      4                      1:5K   Acer Therapeutics Inc.            DONNELLEY FIN… File16/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Form 4 Submission -- doc4.xml/3.6                   HTML      3K 




        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 

 
Plain Text rendering:  Form 4 Submission
 
                                                                                                                                                                                
Ownership Document
 
Schema Version:  X0306
Document Type:  4
Period of Report:  6/19/22
Not Subject to Section 16:  0
Issuer:
Issuer CIK:  1069308
Issuer Name:  Acer Therapeutics Inc.
Issuer Trading Symbol:  ACER
Reporting Owner:
Reporting Owner ID:
Owner CIK:  1934603
Owner Name:  Hayden Tanya
Reporting Owner Address:
Owner Street 1:  300 WASHINGTON STREET
Owner Street 2:  ONE GATEWAY CENTER, SUITE 356
Owner City:  NEWTON
Owner State:  MA
Owner ZIP Code:  02458
Owner State Description:
Reporting Owner Relationship:
Is Director?  No
Is Officer?  Yes
Is Ten Percent Owner?  No
Is Other?  No
Officer Title:  Chief Operating Officer
Derivative Table:
Derivative Transaction:
Security Title:
Value:  Employee Stock Option (right to buy)
Conversion or Exercise Price:
Value:  1.76
Transaction Date:
Value:  6/19/22
Deemed Execution Date:
Transaction Coding:
Transaction Form Type:  4
Transaction Code:  A
Equity Swap Involved?  No
Transaction Timeliness:
Value:
Transaction Amounts:
Transaction Shares:
Value:  25,000
Transaction Price Per Share:
Value:  0.00
Transaction Acquired-Disposed Code:
Value:  A
Exercise Date:
Footnote ID:  F1
Expiration Date:
Value:  6/19/32
Underlying Security:
Underlying Security Title:
Value:  Common Stock
Underlying Security Shares:
Value:  25,000
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  25,000
Ownership Nature:
Direct or Indirect Ownership:
Value:  D
Footnotes:
Footnote - F1The option vests and becomes exercisable over four years as follows: 25% of the shares vest on June 19, 2023, and the remaining 75% of the shares vest quartrly over the remaining three years.
Remarks:
Owner Signature:
Signature Name:  /s/ Harry S. Palmin, Attorney-in-Fact
Signature Date:  6/22/22


Top
Filing Submission 0001209191-22-038667   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 1:42:30.1am ET